Inventor · disambiguated record
Tetsu Akiyama
Also filed as: AKIYAMA TETSU
8 granted patents·5 pending applications·7 citations·filing 2000–2024
76Inventor score
Files withUNIV TOKYO5DAIICHI SEIYAKU CO2KYOWA HAKKO KOGYO KK2TAK CIRCULATOR CO LTD2TAISHO PHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
13 records- 0169US7250488B1Transcriptional activation inhibitory proteinKYOWA HAKKO KOGYO KK·Filed 2000·Granted Jul 31, 2007·5 cites·4 claims
- 0265US11312956B2Nucleic acid inhibiting expression of the MEX3B gene, MEX3B gene expression inhibitor, method for inhibiting MEX3B gene expression, and prophylactic or therapeutic agent for disease caused by MEX3B gene expressionTAK CIRCULATOR CO LTD·Filed 2017·Granted Apr 26, 2022·1 cites·1 claims
- 0357US2025009827A1Pharmaceutical, food, and cosmetic compositions and productsUNIV TOKYO·Filed 2024·Application pending·0 cites
- 0456US7297779B2Colon cancer metastasis inhibitorDAIICHI SEIYAKU CO·Filed 2003·Granted Nov 20, 2007·1 cites·1 claims
- 0554US7491802B2Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancerTAKEDA PHARMACEUTICAL·Filed 2004·Granted Feb 17, 2009·0 cites·11 claims
- 0652US2025375498A1Neurotrimin function inhibitorUNIV TOKYO·Filed 2023·Application pending·0 cites
- 0747US2022333110A1Nucleic acid that inhibits expression of mex3b gene, mex3b gene expression inhibiting agent, method for inhibiting mex3b gene expression, and prophylactic or therapeutic agent for disease caused by mex3b gene expressionUNIV TOKYO·Filed 2020·Application pending·0 cites
- 0843US2023183698A1Prophylactic or therapeutic agent for at least one type of cancer selected from group consisting of pancreatic cancer, lung cancer, colorectal cancer, cholangiocarcinoma and liver cancer, prophylactic or therapeutic agent for said cancer which is used in combination drug in combination with said agent, combination drug comprising said agents, and method for screening for prophylactic or therapeutic agent for cancerUNIV TOKYO·Filed 2021·Application pending·0 cites
- 0940US7422906B2Apoptosis-inducing gene and utilization of the sameTAISHO PHARMACEUTICAL CO LTD·Filed 2004·Granted Sep 9, 2008·0 cites·3 claims
- 1040US2021163610A1Refractory asthma prophylactic/therapeutic agent screening method, and refractory asthma prophylactic/therapeutic agentUNIV TOKYO·Filed 2019·Application pending·0 cites
- 1139US7705196B2sFRP expression enhancing agentDAIICHI SEIYAKU CO·Filed 2005·Granted Apr 27, 2010·0 cites·8 claims
- 1233US11279935B2Method for screening prophylactic or therapeutic agents for diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5 and agent for the prevention or treatment of diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5TAK CIRCULATOR CO LTD·Filed 2017·Granted Mar 22, 2022·0 cites·4 claims
- 1332US7358348B2β-catenin nuclear localized proteinKYOWA HAKKO KOGYO KK·Filed 2001·Granted Apr 15, 2008·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Tetsu Akiyama files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →